Based in Tokyo, Ms Masamune will lead the strategy for évolis®, Cellmid's Australian FGF5 inhibitor hair growth product brand, to be launched in Japan and other parts of Asia.
An accomplished senior diplomat living and working in North and South East Asia for 25 years, Ms Masamune dedicated her career to assisting Australian companies establishing businesses in the region.
Dr David King, chairman, commented:
"We are delighted to welcome Elizabeth onto the Board of Advangen Inc., as a non-executive director.
"Elizabeth's unparalleled experience and contacts in Asian trade and business will be critical in the successful launch of the évolis® brand in the region."
Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.